Please ensure Javascript is enabled for purposes of website accessibility
Cory Renauer

Cory Renauer


Cory is a long-term minded analyst focused on the Healthcare Sector. He genuinely enjoys cutting through the complexity to help everyday investors make better decisions.

Recent articles


Teladoc Health Stock: Buy the Dip?

The company's earnings outlook isn't nearly as bad as the recent stock price beating suggests.


Is TransEnterix a Good Stock to Buy Now?

Shares of the robotic surgical-system manufacturer are soaring, but can this company become the next Intuitive Surgical?


Is Galapagos Stock a Bad-News Buy Right Now?

Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.


3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring

Here's why this stock's big run-up in recent months could be just the beginning.


Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected

If authorized for emergency use later this month, the White House expects just a few million doses of Johnson & Johnson's coronavirus vaccine candidate in its inventory by the end of February.


3 Top Healthcare Stocks to Buy Now

Find out how shares of these disruptive businesses could make you rich.


3 Reasons to Buy Ocular Therapeutix Stock Right Now

There are a few reasons this could be the best biotech stock you can buy at the moment.


Is Ocugen a Buy After Doubling Last Week?

This company's coronavirus vaccine partner took some big steps forward.


Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program

Despite solid signs of efficacy in mid-stage trials, the partners are shutting down all clinical trials with ziritaxestat.


Can KalVista Pharmaceuticals Stock Fly Higher?

Can this under-the-radar biotech and its hereditary angioedema candidate produce more gains for investors?


Should You Sell Cassava Sciences Stock Now?

Can this company's Alzheimer's disease candidate deliver further gains ahead?


Here's Why Investors Should Remember These 2 Healthcare Lessons in 2021

If you're thinking about investing in healthcare stocks this year, remember these two things.


The Scariest Part of Intuitive Surgical's Latest Earnings Call

Here's why shares of the surgical robotics company have been under pressure.


1 Big Problem in Johnson & Johnson's Latest Earnings Call

The coronavirus pandemic continues to pressure one of the company's big operating segments.


2 Green Flags for Abbott Labs and 1 Red Flag

Coronavirus testing won't last forever, but the future still looks bright for Abbott Labs.


Is Abbott Labs a Good Stock to Buy Now?

Luckily, coronavirus tests aren't this company's only rising source of revenue.


2 Green Flags in Intuitive Surgical's Q4 Earnings

Despite a tough year, there were two big sources of encouragement from the surgical robotics leader.


2 Green Flags in Johnson & Johnson's Latest Earnings Report

Strong pharmaceutical sales and an impressive growth forecast gave investors reasons to smile.


Here's Why Novavax Can Beat Johnson & Johnson in the COVID-19 Vaccine Race

Johnson & Johnson's coronavirus vaccine offers one-shot convenience, but Novavax has clear advantages.


Here's Why Pfizer's a Great Stock to Buy and Hold Now

Around $15 billion from coronavirus vaccine sales this year will be just the beginning.